Personalized Medicines in Oncology Market - Forecast(2021 - 2026)

Report Code: HCR 0097 Report Format: PDF + Excel (Delivery in 48 Hrs)

Personalized Medicines in Oncology Market Overview

The Personalized Medicines in Oncology Market size is estimated to reach $263.86bn by 2025, growing at a CAGR of 11.8% during the forecast period 2020-2025. Oncology is a branch of medicine that deals with the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others. According to the WHO reports, cancer is the second leading cause of death with 9.8 million death in 2018, and 70% of cancer deaths are countries with low and middle income. The advancement in science and the increase in the latest technology has driven the best drugs and treatments for the patients to get them cured in less time, the personalized medicines are the medicines that are made depending upon the type of cancer and the type of immunity system of the patient. This modification and advancement in the drugs depending on the patient type is driving the market for personalized medicines in the oncology market

Personalized Medicines in Oncology Market Report Coverage

The report: “Personalized Medicines In Oncology Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Personalized Medicines In Oncology Market. 
By Cancer Type: Blood cancer, Breast Cancer, Intestinal Cancer, Prostate Cancer, Respiratory/Lung cancer, Skin Cancer, Bone Cancer, and Others
By Service: Molecular Oncopathology, Genome Diagnostics, Radiation Therapy, Oncology Testing, Chemotherapy, and Others
By Technology: Next-Generation Sequencing, Fluorescence/ Chromogenic In Situ Hybridization, Immunohistochemistry, Microarray, Quantitative PCR, High Throughput SNP Analysis, and Others
By End-Users: Research Centers, Governmental Institutions, Hospitals, Clinical centers, and Others
By Geography: North America, Asia-Pacific, Europe, and Rest of the World

Key Takeaways

  • Geographically, North America’s Personalized Medicines In Oncology Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high disposal income and increased cancer patients.
  • The increase in health concern and increased prevalence of diseases like cancers, cardiovascular issues, and other infections and allergies are driving the market for Personalized Medicines In Oncology during the forecast period 2020-2025.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Personalized Medicines In Oncology Market report.
  • The advancement in the latest technology and research being made to develop drugs depending on the ability of the patient to the medicines and tumor are driving the manufacturing of personalized medicines and helping in the growth of the market.

Personalized Medicines in Oncology Market Segment Analysis - By Cancer Type

The Application segment of Personalized Medicines In Oncology Market has Blood cancer, Breast Cancer, Intestinal Cancer, Prostate Cancer, Respiratory/Lung cancer, Skin Cancer, Bone Cancer, and Others. The Blood cancer segment, which is sub-segmented into Leukemia, Lymphoma, Multi-Myeloma, registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2025, owing to the increased number of people suffering from different types of blood cancers and increase in requirement of drugs depending upon the type and cause of cancer. According to the WHO reports, it is set to be that about 17% of deaths in women are caused by breast cancer and the need of manufacturing medicine depending on the patient is driving the growth of personalized medicines during the forecast period 2020-2025. 

Personalized Medicines In Oncology Market Segment Analysis - By Technology Type 

The Application segment of the Personalized Medicines In Oncology Market has Fluorescence/ Chromogenic In Situ Hybridization, Next-Generation Sequencing, Immunohistochemistry, High Throughput SNP Analysis, Microarray, Quantitative PCR, and Others. The Next-Generation Sequencing segment registered for the highest market share in 2019, as this process helps in studying the genes of a person and helps in developing medicines so that it can help in curing and as well as in stopping in forwarding of cancer to the next generation. The Immunohistochemistry segment is also set to have growth as this technology helps in finding the antibodies in the body and create medicines to combine with them and fight eh cancer cells. The research made in developing different types of drugs and introducing new types of technology and diagnosis are driving the personalized market during the forecast period 2020-2025. 

Personalized Medicines in Oncology Market Segment Analysis - By Geography

Based on Geography the global Personalized Medicines In Oncology Market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America had a dominant share in terms of revenue in 2019 and it holds the largest market share during the forecast period 2020-2025, owing to the increased health care spending by the people and good health care infrastructure in this region. The rise in population and increasing awareness among people about personalized medicines are driving the market for personalized medicines for oncology in the Asia-pacific region. An increase in the prevalence of different types of cancers and the need for medicines to cure cancer in different types of people in different regions is driving the demand of personalized medicines globally as they help in fighting cancer more effectively than that of general 

Personalized Medicines in Oncology Market Drivers

High prevalence of cancer

The increase in the prevalence of different types of cancer is driving the growth of the market. According to the reports of the National Centre for Biotechnology Information, the majority of cancers are caused owing to the harmful lifestyles in the past, high consumption of tobacco, unhealthy foods. Such factors are driving the usage of personalized medicines depending upon the type and cause of cancer and the ability of the body to withstand and react to the treatment process.

Personalized Medicines in Oncology Market Challenges  

Lack of awareness among the people

The lack of awareness among the people about the personalized medicines for the cancer treatment is challenging the market. The cost involved in the treatment for cancer, and the cost involved in making personalized medicines depending on the type of patient is hampering the growth of the market during the forecast period 2020-2025.

Personalized Medicines in Oncology Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Personalized Medicines In Oncology Market. Key companies of this market are Biotheranostics, Illumina, Inc., DNA Link, Genomic Health, Inc., Cypher Genomics, Life Technologies Corporation, Fulgent Diagnostics, Caris Life Sciences, Ariana Pharma, Diploid, and others.

Acquisitions/Product Launches:

  • In April 2019, FDA approved the Balversa (edafitnib), a targeted therapy that is used in adults for the bladder cancer with a mutation in FGFR3 or FGFR2 gene.
  • In May 2019, Novartis company got approval from the U.S. Food and Drug Administration for Piqray (alpelisib) which is used in combination with Faslodex (fulvestrant) and it is used to treat HER2-negative breast cancer with PIK3CA mutation.


1. Personalized Medicines In Oncology Market - Overview
    1.1 Definitions and Scope
2. Personalized Medicines In Oncology Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends 
    2.2 Key trends by Cancer Type
    2.3 Key trends by Service
    2.4 Key trends by Technology
    2.5 Key trends by End-Users
    2.6 Key trends by Geography
3. Personalized Medicines In Oncology Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Personalized Medicines In Oncology Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Personalized Medicines In Oncology Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Personalized Medicines In Oncology - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Personalized Medicines In Oncology Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2  Opportunities Analysis
    7.3  Market Life Cycle
8. Personalized Medicines In Oncology Market – By Cancer Type (Market Size –$Million/$Billion)
    8.1 Blood cancer
        8.1.1 Leukemia
        8.1.2 Lymphoma
        8.1.3 Multi Myeloma
    8.2 Breast Cancer
    8.3 Intestinal Cancer
    8.4 Prostate Cancer
    8.5 Respiratory/Lung cancer
    8.6 Skin Cancer
    8.7 Bone Cancer
    8.8 Others
9. Personalized Medicines In Oncology Market – By Service (Market Size –$Million/$Billion)
    9.1 Molecular Oncopathology
    9.2 Genome Diagnostics
    9.3 Radiation Therapy
    9.4 Oncology Testing
    9.5 Chemotherapy
    9.6 Others
10. Personalized Medicines In Oncology Market – By Technology (Market Size –$Million/$Billion)
    10.1 Next-Generation Sequencing
    10.2 Fluorescence/ Chromogenic In Situ Hybridization
    10.3 Immunohistochemistry
    10.4 Microarray
    10.5 Quantitative PCR
    10.6 High Throughput SNP Analysis
    10.7 Others
11. Personalized Medicines In Oncology Market – By End-Users (Market Size –$Million/$Billion)
    11.1 Research Centers
    11.2 Governmental Institutions
    11.3 Hospitals
    11.4 Clinical centers
    11.5 Others
12. Personalized Medicines In Oncology Market -  By Geography (Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Personalized Medicines In Oncology Market - Entropy
14. Personalized Medicines In Oncology Market – Industry/Segment Competition Landscape      Premium  
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Best Practices for Companies
15. Personalized Medicines In Oncology Market – Key Company List by Country Premium  Premium
16. Personalized Medicines In Oncology Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Personalized Medicines In Oncology Market Overview 2019-2024
Table 2: Personalized Medicines In Oncology Market Leader Analysis 2018-2019 (US$)
Table 3: Personalized Medicines In Oncology Market Product Analysis 2018-2019 (US$)
Table 4: Personalized Medicines In Oncology Market End User Analysis 2018-2019 (US$)
Table 5: Personalized Medicines In Oncology Market Patent Analysis 2013-2018* (US$)
Table 6: Personalized Medicines In Oncology Market Financial Analysis 2018-2019 (US$)
Table 7: Personalized Medicines In Oncology Market Driver Analysis 2018-2019 (US$)
Table 8: Personalized Medicines In Oncology Market Challenges Analysis 2018-2019 (US$)
Table 9: Personalized Medicines In Oncology Market Constraint Analysis 2018-2019 (US$)
Table 10: Personalized Medicines In Oncology Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Personalized Medicines In Oncology Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Personalized Medicines In Oncology Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Personalized Medicines In Oncology Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Personalized Medicines In Oncology Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Personalized Medicines In Oncology Market Value Chain Analysis 2018-2019 (US$)
Table 16: Personalized Medicines In Oncology Market Pricing Analysis 2019-2024 (US$)
Table 17: Personalized Medicines In Oncology Market Opportunities Analysis 2019-2024 (US$)
Table 18: Personalized Medicines In Oncology Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Personalized Medicines In Oncology Market Supplier Analysis 2018-2019 (US$)
Table 20: Personalized Medicines In Oncology Market Distributor Analysis 2018-2019 (US$)
Table 21: Personalized Medicines In Oncology Market Trend Analysis 2018-2019 (US$)
Table 22: Personalized Medicines In Oncology Market Size 2018 (US$)
Table 23: Personalized Medicines In Oncology Market Forecast Analysis 2019-2024 (US$)
Table 24: Personalized Medicines In Oncology Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 26: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Genomics, 2019-2024 ($)
Table 27: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Proteomics, 2019-2024 ($)
Table 28: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Metabolomics, 2019-2024 ($)
Table 29: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Epigenetics, 2019-2024 ($)
Table 30: Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 31: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Molecular Oncopathology, 2019-2024 ($)
Table 32: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Genome Diagnostics, 2019-2024 ($)
Table 33: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Radiation Therapy, 2019-2024 ($)
Table 34: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Oncology Testing, 2019-2024 ($)
Table 35: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Chemotherapy, 2019-2024 ($)
Table 36: Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 37: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Next-Generation Sequencing, 2019-2024 ($)
Table 38: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Fluorescence/ Chromogenic In Situ Hybridization, 2019-2024 ($)
Table 39: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Immunohistochemistry, 2019-2024 ($)
Table 40: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Microarray, 2019-2024 ($)
Table 41: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Quantitative PCR, 2019-2024 ($)
Table 42: Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 43: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Colorectal/ stomach/ esophageal, 2019-2024 ($)
Table 44: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Ovarian, 2019-2024 ($)
Table 45: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Lung, 2019-2024 ($)
Table 46: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Brest, 2019-2024 ($)
Table 47: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Sarcoma, 2019-2024 ($)
Table 48: Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 49: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Research Centers, 2019-2024 ($)
Table 50: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Governmental Institutions, 2019-2024 ($)
Table 51: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Hospitals, 2019-2024 ($)
Table 52: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 53: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 54: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 55: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 56: North America Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 57: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 58: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 59: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 60: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 61: South america Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 62: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 63: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 64: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 65: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 66: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 67: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 68: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 69: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 70: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 71: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 72: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 73: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 74: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 75: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 76: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 77: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 78: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 79: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 80: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 81: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 82: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 83: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 84: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 85: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 86: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 87: Top Companies 2018 (US$)Personalized Medicines In Oncology Market, Revenue & Volume
Table 88: Product Launch 2018-2019Personalized Medicines In Oncology Market, Revenue & Volume
Table 89: Mergers & Acquistions 2018-2019Personalized Medicines In Oncology Market, Revenue & Volume


List of Figures

Figure 1: Overview of Personalized Medicines In Oncology Market 2019-2024
Figure 2: Market Share Analysis for Personalized Medicines In Oncology Market 2018 (US$)
Figure 3: Product Comparison in Personalized Medicines In Oncology Market 2018-2019 (US$)
Figure 4: End User Profile for Personalized Medicines In Oncology Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Personalized Medicines In Oncology Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Personalized Medicines In Oncology Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Personalized Medicines In Oncology Market 2018-2019
Figure 8: Ecosystem Analysis in Personalized Medicines In Oncology Market 2018
Figure 9: Average Selling Price in Personalized Medicines In Oncology Market 2019-2024
Figure 10: Top Opportunites in Personalized Medicines In Oncology Market 2018-2019
Figure 11: Market Life Cycle Analysis in Personalized Medicines In Oncology Market
Figure 12: GlobalBy Tumore TypePersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy ServicePersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy TechnologyPersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy OccurrencePersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 16: GlobalBy End UserPersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 17: Global Personalized Medicines In Oncology Market - By Geography
Figure 18: Global Personalized Medicines In Oncology Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 19: Global Personalized Medicines In Oncology Market CAGR, By Geography, 2019-2024 (%)
Figure 20: North America Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 21: US Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 63: U.K Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 96: China Personalized Medicines In Oncology Market Value & Volume, 2019-2024
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($)Personalized Medicines In Oncology Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Personalized Medicines In Oncology Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 125: Russia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%)Personalized Medicines In Oncology Market
Figure 134: Developments, 2018-2019*Personalized Medicines In Oncology Market
Figure 135: Company 1 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 8 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)